Related Experiment Video
Updated: May 6, 2026

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia
Hong Zhang1, Meritxell Alberich-Jorda, Giovanni Amabile
1Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02215, USA; Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Abstract:
Mutation or epigenetic silencing of the transcription factor C/EBPα is observed in ∼10% of patients with acute myeloid leukemia (AML). In both cases, a common global gene expression profile is observed, but downstream targets relevant for leukemogenesis are not known. Here, we identify Sox4 as a direct target of C/EBPα whereby its expression is inversely correlated with C/EBPα activity. Downregulation of Sox4 abrogated increased self-renewal of leukemic cells and restored their differentiation. Gene expression profiles of leukemia-initiating cells (LICs) from both Sox4 overexpression and murine C/EBPα mutant AML models clustered together but differed from other types of AML. Our data demonstrate that Sox4 overexpression resulting from C/EBPα inactivation contributes to the development of leukemia with a distinct LIC phenotype.
Insights
Transcription factor C/EBPα inactivation in acute myeloid leukemia (AML) leads to Sox4 overexpression. This contributes to leukemia development by promoting self-renewal and inhibiting differentiation of leukemia-initiating cells (LICs).
Area of Science:
- Molecular Biology
- Cancer Research
- Hematology
Background:
- Transcription factor CCAAT/enhancer-binding protein alpha (C/EBPα) is frequently inactivated in acute myeloid leukemia (AML).
- Inactivation of C/EBPα leads to a common gene expression profile in AML, but downstream targets driving leukemogenesis remain unclear.
Purpose of the Study:
- To identify direct downstream targets of C/EBPα in AML.
- To investigate the role of these targets in regulating leukemia-initiating cell (LIC) phenotype and function.
Main Methods:
- Gene expression profiling to compare AML models with C/EBPα inactivation and Sox4 overexpression.
- Functional assays to assess the impact of Sox4 modulation on leukemic cell self-renewal and differentiation.
- Analysis of leukemia-initiating cells (LICs) from genetically modified murine AML models.
Main Results:
- Sox4 was identified as a direct transcriptional target of C/EBPα, with inverse correlation between their activities.
- Downregulation of Sox4 reversed the aberrant self-renewal and restored differentiation in leukemic cells.
- Gene expression profiles of LICs from Sox4-overexpressing and C/EBPα-mutant AML models showed distinct clustering.
Conclusions:
- Sox4 overexpression, driven by C/EBPα inactivation, is a key mechanism contributing to AML pathogenesis.
- Sox4 plays a critical role in conferring a distinct leukemia-initiating cell phenotype in specific AML subtypes.
Related Concept Videos
Pleiotropy
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes

